ABU DHABI, UAE, Dec. 30, 2025 /PRNewswire/ -- Anghami Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/ANGH">ANGH</a>) (&#34;Anghami&#34;), the leading music and entertainment streaming platform in the MENA region, today announced its results for the six-month period ended 30 June 2025, underscoring the benefits of the OSN+ integration and the impact of its transformative partnership with Warner Bros. Discovery.

HIGHLIGHTS
<ul xmlns="http://www.w3.org/1999/xhtml" type="disc"><li xmlns="http://www.w3.org/1999/xhtml">Revenue growth of 97% year-on-year to US$48.4 million for the six month period ended 30 June 2025, driven by OSN+ integration and expanding subscription income.</li><li xmlns="http://www.w3.org/1999/xhtml">Paid subscriber base doubled to 3.54 million as of 30 June 2025, with over 120 million total registered users, demonstrating strong platform conversion rates.</li><li xmlns="http://www.w3.org/1999/xhtml">Strategic investment by Warner Bros. Discovery worth US$57 million in OSN Streaming Ltd., the majority owner of Anghami, reinforcing exclusive content partnerships and bringing HBO, Max Originals, and global entertainment to MENA audiences.</li><li xmlns="http://www.w3.org/1999/xhtml">New OSN+ partnerships with Noon and PlayStation during the period as well as a distribution agreement with Talabat.</li></ul>Commenting on Anghami&#39;s results, Elie Habib, CEO of Anghami, said: &#34;H1 2025 revenue reached US$48.4 million, driven by subscription income rising to US$43 million following the OSN+ integration. On the operational side, we delivered 99.9% uptime and improved app store ratings from 3.8 to 4.6 stars. Warner Bros. Discovery&#39;s US$57 million investment in OSN Streaming reinforces our partnership and keeps HBO, Max Originals, and global hits exclusive to OSN+ viewers across MENA. Looking ahead, our new collaboration with Talabat expands OSN+ distribution and positions us to accelerate subscriber growth through 2026 and beyond.&#34;
The first half of 2025 marked transformative operational achievements for Anghami, driven by the successful OSN+ platform integration and strategic content partnerships. Paid subscribers grew 97% year-on-year to 3.54 million as of 30 June 2025, with total registered users exceeding 120 million across the MENA region driving revenue growth of 97% year-on-year to US$48.4 million. However, the increased investments made to support subscriber acquisition for OSN+ and other integration costs impacted profitability, resulting in a loss of US$ 37.1 million. The management team is implementing measures to adjust the cost base and further drive the benefits of the business scaling up.
The Warner Bros. Discovery investment has provided exclusive access to HBO content, Max Originals, and international entertainment, establishing Anghami as the premier streaming destination in MENA. Platform integration delivered seamless music and video content access through a unified interface, driving strong conversion rates from music-only to comprehensive entertainment subscriptions.
Distribution expansion through PlayStation and Noon.com partnerships with OSN+ opened new customer acquisition channels, while high-profile live events including the Amr Diab &amp; Adam Port concert in Abu Dhabi and Nancy Ajram Riyadh Boulevard activation reinforced Anghami&#39;s cultural leadership position.
Following the period end, Anghami strengthened its ecosystem through a distribution deal with Talabat, creating new content distribution and user acquisition channels expected to drive growth momentum.
The company has confirmed major content launches for early 2026, including exclusive regional productions and expanded international content partnerships that will further establish the platform&#39;s competitive differentiation in the streaming market.
OUTLOOK
Anghami is positioned to capitalize on accelerating digital entertainment demand across the MENA region. The company&#39;s strategic partnerships provide multiple growth drivers and expanding content capabilities that differentiate the platform in the competitive streaming market.
The Warner Bros. Discovery partnership will drive continued subscriber acquisition throughout 2025 and 2026.
Management expects topline growth to continue in H2 whilst the investments required to drive integration benefits will continue to impact profitability until operational synergies and cost management measures are more fully realized, and the combined platform achieves optimal scale utilization across all markets.
The full unaudited financial statements and notes for the six-month period ended 30 June 2025 were furnished to the U.S. Securities and Exchange Commission (the &#34;SEC&#34;) today and may be accessed by visiting either the SEC&#39;s website at <a xmlns="http://www.w3.org/1999/xhtml" href="https://www.sec.gov/" target="_blank" rel="nofollow">www.sec.gov</a> or Anghami&#39;s website at <a xmlns="http://www.w3.org/1999/xhtml" href="https://www.anghami.com/investors" target="_blank" rel="nofollow">https://www.anghami.com/investors</a>. 
About Anghami Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/ANGH">ANGH</a>) 
Anghami is the leading multi-media technology streaming platform in the Middle East and North Africa (&#34;MENA&#34;) region, offering a comprehensive ecosystem of exclusive premium video, music, podcasts, live entertainment, audio services, and more.
With a user base exceeding 120 million registered users and 3.5 million paid subscribers, Anghami has partnered with 47 telcos across MENA, facilitating customer acquisition and subscription payment, in addition to establishing relationships with major film studios, entertainment giants, and music labels, both regional and international. Headquartered in Abu Dhabi, UAE, Anghami operates in 16 countries across MENA, with offices in Beirut, Dubai, Cairo, and Riyadh.
To learn more about Anghami, please visit: <a xmlns="http://www.w3.org/1999/xhtml" href="https://anghami.com" target="_blank" rel="nofollow">https://anghami.com</a>. Any questions for the Investors Relations Department can be emailed to <a xmlns="http://www.w3.org/1999/xhtml" href="mailto:IR@anghami.com" target="_blank" rel="nofollow">IR@anghami.com</a> or <a xmlns="http://www.w3.org/1999/xhtml" href="mailto:anghami@apcoworldwide.com" target="_blank" rel="nofollow">anghami@apcoworldwide.com</a>.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains &#34;forward-looking statements&#34; within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Anghami&#39;s actual results may differ from its expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as &#34;expect,&#34; &#34;estimate,&#34; &#34;start,&#34; &#34;project,&#34; &#34;budget,&#34; &#34;forecast,&#34; &#34;preliminary,&#34; &#34;anticipate,&#34; &#34;position,&#34; &#34;intend,&#34; &#34;plan,&#34; &#34;may,&#34; &#34;will,&#34; &#34;could,&#34; &#34;should,&#34; &#34;believes,&#34; &#34;continue,&#34; &#34;predicts,&#34; &#34;potential,&#34; &#34;transform,&#34; &#34;commitment&#34; and similar expressions (or the negative versions of such words or expressions) are intended to identify such forward-looking statements. These statements include those related to the effect of the OSN+ integration, Warner Bros. Discovery investment in OSN Streaming, other new partnerships and collaborations, and future growth. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from those discussed in the forward-looking statements. Most of these factors are outside Anghami&#39;s control and are difficult to predict. Factors that may cause such differences include, but are not limited to: the outcome of any legal proceedings that may be instituted against Anghami; changes in applicable laws or regulations; and the possibility that Anghami may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties identified in Anghami&#39;s fiscal 2024 annual report on Form 20-F filed with the SEC on April 30, 2025, including those under &#34;Risk Factors&#34; therein, and in other documents filed or to be filed with the SEC by Anghami and available at the SEC&#39;s website at <a xmlns="http://www.w3.org/1999/xhtml" href="https://www.sec.gov" target="_blank" rel="nofollow">www.sec.gov</a>. Anghami cautions that the foregoing list of factors is not exclusive. Anghami cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Except as required by law, Anghami does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based.




<img xmlns="http://www.w3.org/1999/xhtml" title="Cision" width="12" height="12" alt="Cision" src="https://edge.prnewswire.com/c/img/favicon.png?sn=LN54942&amp;sd=2025-12-30"></img> View original content:<a xmlns="http://www.w3.org/1999/xhtml" id="PRNURL" rel="nofollow" href="https://www.prnewswire.com/news-releases/anghami-reports-h1-2025-financial-results-marked-by-topline-growth-and-transformative-deal-with-warner-bros-discovery-302650948.html" target="_blank">https://www.prnewswire.com/news-releases/anghami-reports-h1-2025-financial-results-marked-by-topline-growth-and-transformative-deal-with-warner-bros-discovery-302650948.html</a>
SOURCE Anghami Inc.

ABU DHABI, UAE, Dec. 30, 2025 /PRNewswire/ -- Anghami Inc. (NASDAQ:ANGH) (&#34;Anghami&#34;), the leading music and entertainment streaming platform in the MENA region, today announced its results for the six-month

ANGH

ANGHAMI REPORTS H1 2025 FINANCIAL RESULTS; MARKED BY TOPLINE GROWTH AND TRANSFORMATIVE DEAL WITH WARNER BROS. DISCOVERY

PRNewswire

Anghami's revenue grew 97% to $48.4 million in H1 2025.
Paid subscribers doubled to 3.54 million amid OSN+ integration.
Warner Bros. Discovery invested $57 million, enhancing content offerings.
New partnerships with Noon and PlayStation boosted user acquisition channels.
Profitability impacted by subscriber acquisition costs, leading to $37.1 million loss.

Raanana, Israel, Jan.  02, 2026  (GLOBE NEWSWIRE) --  As the 2025-2026 flu season intensifies across the United States, a mutated strain of influenza A is driving most cases, sparking concerns about a potentially tough

PLRZ

As Flu Surge Continues, Polyrizon's Nasal Spray Emerges as Potential Extra Shield Solution for Both Vaccinated and Unvaccinated

Globe Newswire

Flu season intensifies, driven by a mutated influenza A strain.
Polyrizon's PL-16 offers a non-pharmaceutical solution for flu prevention.
PL-16 shows over 90% protection in preclinical studies against viral infections.
FDA submission for PL-16 could lead to over-the-counter availability.
Negative vaccination trends leave populations vulnerable, increasing demand for alternatives.

Hauppauge, NY, Dec.  29, 2025  (GLOBE NEWSWIRE) --  — Cemtrex, Inc. (NASDAQ:CETX, CETXP)) (&#34;Cemtrex&#34; or the &#34;Company&#34;), a diversified technology company operating in security and industrial markets, today reported

CETX

Cemtrex Reports Full Fiscal Year 2025 Financial Results

Cemtrex reported a revenue increase to $76.5 million for FY 2025.
Operating income returned to positive at $0.5 million from a loss of $5.3 million.
The Security segment grew by 20% with revenues of $38.4 million.
Cemtrex improved liquidity by $9 million and reduced debt by $7.8 million.
Acquisitions are in process to further enhance revenue and operating income.

— First Half Revenue of HK$178.2 million (US$22.8 million), increase 81.3% year-over-year —— First Half Net Income of HK$12.5 million (US$1.6 million), versus Net Income of HK$6.9 million last year —      HONG KONG, Jan.

CHOW

ChowChow Cloud International Holdings Limited Announces First Half 2025 Unaudited Financial Results

CHOW's revenues rose 81.3% to HK$178.2 million.
Net income increased by 80% to HK$12.5 million.
New customer projects contributed 46.9% to total revenue.
Gross profit margin remained stable at 12.3% despite rising costs.
The company plans to expand its operations in Asia Pacific.

FONAR stockholders to receive $19.00 per share of common stock, in an all-cash transactionMelville, New York--(Newsfile Corp. - December 29, 2025) - FONAR Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/FONR">FONR</a>) ("FONAR" or the "Company"), The Inventor of MR Scanning&#8482;, today confirmed that it entered into a definitive agreement on December 23, 2025 (the "Merger Agreement") with FONAR, LLC and FONAR Acquisition Sub, Inc. (collectively, "Buyer"), under which, subject to the satisfaction of the conditions set forth in the Merger Agreement, Buyer will acquire all of the issued and outstanding shares of the Company (other than shares owned by Buyer, the members of the Acquisition Group or shares held in treasury by the Company or its direct or indirect subsidiaries), for an amount in cash equal to $19.00 per share of the Company's common stock, $19.00 per share of the Company's Class B common stock, $6.34 per share of the Company's Class C common stock and $10.50 per share of the Company's Class A non-voting preferred stock (the "Transaction"). Buyer is controlled by the previously disclosed acquisition group led by Chief Executive Officer Timothy Damadian and consisting of certain members of the Company's management team and board of directors (the "Board") and third parties (collectively, the "Acquisition Group"). A special committee of the Board, consisting solely of disinterested members of the Board (the "Special Committee"), in consultation with its independent financial and legal advisors, unanimously recommended the entry into the Merger Agreement and the Transaction, and the Board (excluding directors that are members of the Acquisition Group who recused themselves from the vote) unanimously approved the entry into the Merger Agreement. Subject to the satisfaction of the conditions set forth in the Merger Agreement, holders of the Company's common stock will receive $19.00 per share in cash at the closing of the Transaction. The Transaction price per share of the Company's common stock represents a 31.5% premium to the closing share price on the Nasdaq Capital Market on the last trading day prior to the announcement of the Transaction, a 21.9% premium to the closing share price on the Nasdaq Capital Market on July 8, 2025 (the last trading day prior to the announcement of the Acquisition Group's initial non-binding proposal), and a 39.7% premium over the average closing price of the common stock for the 90 trading day trading period ending on June 30, 2025.Transaction Terms, Timing and ApprovalsThe Transaction is expected to close in the third fiscal quarter of 2026 and is subject to the satisfaction of a number of customary closing conditions more thoroughly described in the Merger Agreement, including the approval at a special meeting of the Company's stockholders (the "Company Stockholders Meeting") by the affirmative vote (i) of the holders of a majority in voting power of the Company's capital stock outstanding and entitled to vote, and (ii) of a majority of the votes cast by disinterested stockholders, and is subject to other customary closing conditions. The Transaction is not subject to any financing conditions.The Company expects to release its customary financial results for the second quarter ended December 31, 2025 in February 2026.Upon completion of the Transaction, the Company's common stock will no longer be listed on the Nasdaq Stock Market.The Transaction is being financed by Buyer through a combination of new debt, new equity and rollover of Company securities. Buyer has secured a commitment for a debt financing facility in the amount of $35 million from OceanFirst Bank, N.A., which commitment is subject to usual and customary closing conditions. The remaining debt of approximately $10 million and equity comprised of approximately $45 million is being provided by members of the Acquisition Group and third party lenders. The third party debt is subordinate to the OceanFirst Bank financing facility.AdvisorsMarshall &#38; Stevens Transaction Advisory Services LLC is serving as financial advisor to the Special Committee, and Meister Seelig &#38; Fein PLLC is serving as legal counsel to the Special Committee. DLA Piper LLP (US) is serving as legal counsel to the Company. Moritt Hock &#38; Hamroff LLP is serving as legal counsel to Buyer.Cautionary Statement Concerning Forward-Looking StatementsThis press release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Certain statements contained in this press release, including those that express a belief, expectation or intention, as well as those that are not statements of historical fact, are forward-looking statements within the meaning of the federal securities laws and as such are based upon the Company's current beliefs as to the outcome and timing of future events. Forward-looking statements are generally identifiable by use of forward-looking terminology such as "approximately," "anticipate," "assume," "believe," "budget," "contemplate," "continue," "could," "estimate," "expect," "future," "hypothetical," "intend," "may," "outlook," "plan," "potential," "predict," "project," "seek," "should," "target," "will" or other similar words or expressions. There can be no assurance that actual results of forward-looking statements, including but not limited to the consummation of the proposed Transaction, including the Merger, or those pertaining to expectations regarding the Company's financial performance, expectations as to the likelihood and timing of closing of acquisitions, dispositions, or other transactions, and changes in local, regional, and national economic conditions, including as a result of the systemic and structural changes in the healthcare industry. Forward-looking statements presented herein are based on management's beliefs and assumptions made by, and information currently available to, management.The forward-looking statements contained in this press release are based on historical performance and management's current plans, estimates and expectations in light of information currently available to the Company and are subject to uncertainty and changes in circumstances. There can be no assurance that future developments affecting the Company will be those that it has anticipated. Many factors, including the following, could cause actual results to differ materially from the forward-looking statements set forth in this press release: the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement; the outcome of any legal proceedings that may be instituted against the Company and others following announcement of the Merger Agreement; the inability to complete the proposed Transaction, including the Merger, due to the failure to satisfy any condition to the Closing, including that the Company obtains the requisite approvals of its stockholders and other Closing conditions described in the Merger Agreement; risks that the proposed Merger disrupts current plans and operations of the Company; potential difficulties in employee retention as a result of the proposed Transaction; legislative, regulatory and economic developments; risks related to disruption of management's attention from the Company's ongoing business operations due to the proposed Transaction; the effect of the announcement of the proposed Transaction on the Company's relationships with referral sources and vendors, operating results and business generally, changes in global, regional or local political, economic, business, competitive, market, regulatory and other factors described in the Company's news releases and filings with the SEC, including but not limited to those described in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2025, as filed with the SEC on September 22, 2025 (the "Form 10-K") under the heading "Risk Factors" and in the Company's subsequent reports filed with the SEC, many of which are beyond the Company's control. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove to be incorrect, the Company's actual results may vary in material respects from what it may have expressed or implied by these forward-looking statements. The Company cautions that you should not place undue reliance on any of its forward-looking statements. Any forward-looking statement made by the Company in this press release speaks only as of the date of this press release. Factors or events that could cause the Company's actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. The Company does not guarantee that the assumptions underlying such forward-looking statements contained in this press release are free from errors. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable securities laws.Additional Information and Where to Find ItThis communication is being made in respect of the Transaction involving the Company and Buyer. In connection with the Transaction, (i) the Company intends to file the relevant materials with the SEC, including a proxy statement on Schedule 14A and (ii) certain participants in the Transaction intend to jointly file with the SEC a Schedule 13E-3 Transaction Statement, which will contain important information on the Company, Buyer and the Transaction, including the terms and conditions of the Transaction. Promptly after filing its definitive proxy statement with the SEC, the Company will mail the definitive proxy statement, the Schedule 13E-3 and a proxy card to each stockholder of the Company entitled to vote at the Company Stockholders Meeting. This communication is not a substitute for the proxy statement, the Schedule 13E-3 or any other document that the Company may file with the SEC or send to its stockholders in connection with the proposed Transaction. The materials to be filed by the Company will be made available to the Company's investors and stockholders at no expense to them and copies may be obtained free of charge on the Company's website at <a href="https://api.newsfilecorp.com/redirect/XExAeiKByX">www.fonar.com/investor-relations.html</a>. In addition, all of those materials will be available at no charge on the SEC's website at <a href="https://api.newsfilecorp.com/redirect/DOq7eFzQ2x">www.sec.gov</a>. Investors and stockholders of the Company are urged to read the proxy statement, the Schedule 13E-3 and the other relevant materials when they become available before making any voting or investment decision with respect to the proposed Transaction because they contain important information about the Company and the proposed Transaction. This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities, or a solicitation of any vote or approval.Stockholders of the Company are urged to read all relevant documents filed with the SEC, including the proxy statement and the Schedule 13E-3 Transaction Statement, as well as any amendments or supplements to these documents, carefully when they become available because they will contain important information about the Transaction.Participants in the Proxy SolicitationThe Company and its directors, executive officers, other members of its management and employees may be deemed to be participants in the solicitation of proxies of the Company stockholders in connection with the Transaction under SEC rules. Investors and stockholders may obtain more detailed information regarding the names, affiliations and interests of the Company's executive officers and directors in the solicitation by reading the Form 10-K, the Company's proxy statement on Schedule 14A filed with the SEC on April 7, 2025, in connection with its 2025 annual meeting of stockholders, and the proxy statement, the Schedule 13E-3 Transaction Statement and other relevant materials that will be filed with the SEC in connection with the Transaction when they become available. Information concerning the interests of the Company's participants in the solicitation, which may, in some cases, be different than those of the Company's stockholders generally, will be set forth in the proxy statement relating to the Transaction and the Schedule 13E-3 Transaction Statement when they become available.WE URGE INVESTORS TO READ THE PROXY STATEMENT, SCHEDULE 13E-3 AND ANY OTHER RELEVANT DOCUMENTS FILED BY THE COMPANY IN CONNECTION WITH THE PROPOSED TRANSACTION WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY, BUYER AND THE PROPOSED TRANSACTION, INCLUDING THE MERGER. INVESTORS ARE URGED TO READ THESE DOCUMENTS CAREFULLY AND IN THEIR ENTIRETY.About FONARFONAR, <a href="https://api.newsfilecorp.com/redirect/7nzEyf0zmw">The Inventor of MR Scanning&#8482;</a>, located in Melville, NY, was incorporated in 1978, and is the first, oldest and most experienced MRI Company in the industry. FONAR went public in 1981 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/FONR">FONR</a>). FONAR sold the world's first commercial MRI to Ronald J. Ross, MD, Cleveland, Ohio. It was installed in 1980. Dr. Ross and his team began the world's first clinical MRI trials in January 1981. The results were reported in the June 1981 edition of Radiology/Nuclear Medicine Magazine and the April 1982 peer-reviewed article in the Journal Radiology. The technique used for obtaining T1 and T2 values was the FONAR technique (Field fOcusing Nuclear mAgnetic Resonance), not the back projection technique. <a href="https://api.newsfilecorp.com/redirect/rpP5DS83gg">www.fonar.com/innovations-timeline.html</a>.FONAR's signature product is the FONAR UPRIGHT&#174; Multi-Position&#8482; MRI (also known as the STAND-UP&#174; MRI), the only whole-body MRI that performs Position&#8482; Imaging (pMRI&#8482;) and scans patients in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as the conventional lie-down position. The FONAR UPRIGHT&#174; Multi-Position&#8482; MRI often detects patient problems that other MRI scanners cannot because they are lie-down, "weightless-only" scanners. The patient-friendly UPRIGHT&#174; MRI has a near-zero patient claustrophobic rejection rate. As a FONAR customer states, "If the patient is claustrophobic in this scanner, they'll be claustrophobic in my parking lot." Approximately 85% of patients are scanned sitting while watching TV.FONAR has new works-in-progress technology for visualizing and quantifying the cerebral hydraulics of the central nervous system, the flow of cerebrospinal fluid (CSF), which circulates throughout the brain and vertebral column at the rate of 32 quarts per day. This imaging and quantifying of the dynamics of this vital life-sustaining physiology of the body's neurologic system has been made possible first by FONAR's introduction of the MRI and now by this latest works-in-progress method for quantifying CSF in all the normal positions of the body, particularly in its upright flow against gravity. Patients with whiplash or other neck injuries are among those who will benefit from this new understanding.FONAR's primary source of income and growth is attributable to its wholly-owned diagnostic imaging management subsidiary, Health Management Company of America (HMCA) <a href="https://api.newsfilecorp.com/redirect/VvxqefPwyo">www.hmca.com</a>.FONAR's substantial list of patents includes recent patents for its technology enabling full weight-bearing MRI imaging of all the gravity sensitive regions of the human anatomy, especially the brain, extremities and spine. It includes its newest technology for measuring the Upright cerebral hydraulics of the cerebrospinal fluid (CSF) of the central nervous system. FONAR's UPRIGHT&#174; Multi-Position&#8482; MRI is the only scanner licensed under these patents.#<a href="https://api.newsfilecorp.com/redirect/ejxOQfDgyL">UPRIGHT&#174;</a>, and <a href="https://api.newsfilecorp.com/redirect/874qysazke">STAND-UP&#174;</a> are registered trademarks. <a href="https://api.newsfilecorp.com/redirect/y4RAJIpEDo">The Inventor of MR Scanning&#8482;</a>, <a href="https://api.newsfilecorp.com/redirect/1KxqyIXv4y">CSP&#8482;</a>, <a href="https://api.newsfilecorp.com/redirect/A8Z7ASgA8w">MultiPosition&#8482;</a>, <a href="https://api.newsfilecorp.com/redirect/ZExXNiakyz">UPRIGHT RADIOLOGY&#8482;</a>, <a href="https://api.newsfilecorp.com/redirect/anxwjfDmKD">pMRI&#8482;</a>, <a href="https://api.newsfilecorp.com/redirect/24NKyID7j1">CFS Videography&#8482;</a>, <a href="https://api.newsfilecorp.com/redirect/MqrOeU3ayM">Dynamic&#8482;</a> and <a href="https://api.newsfilecorp.com/redirect/bg5bvuJ2y0">The Proof is in the Picture&#8482;</a>, are trademarks of FONAR Corporation.This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company's filings with the SEC.<div id="contactInfo"><table cellspacing="0" cellpadding="0" style="text-align: start; width: 100%; border-collapse: collapse;" border="0"><tbody><tr><td style="width: 50%; border-top: 2px solid #000000;">NEWS </td><td style="width: 50%; vertical-align: top; border-top: 2px solid #000000; text-align: right;">Fonar Corporation</td></tr><tr><td style="width: 50%;">For Immediate Release</td><td style="width: 50%; vertical-align: top; text-align: right;">The Inventor of MR Scanning&#8482;</td></tr><tr><td style="width: 50%;">Contact: Daniel Culver</td><td style="width: 50%; vertical-align: top; text-align: right;">An ISO 13485 Company</td></tr><tr><td style="width: 50%;">Director of Communications</td><td style="width: 50%; vertical-align: top; text-align: right;">Melville, New York 11747</td></tr><tr><td style="width: 50%;">E-mail: <a href="mailto:investor@fonar.com">investor@fonar.com</a></td><td style="width: 50%; vertical-align: top; text-align: right;">Phone: (631) 694-2929</td></tr><tr><td style="width: 50%; border-bottom: 2px solid #000000;"><a href="https://api.newsfilecorp.com/redirect/3KXxyIrxvN">www.fonar.com</a></td><td style="width: 50%; vertical-align: top; border-bottom: 2px solid #000000; text-align: right;">Fax: (631) 390-1772</td></tr></tbody></table></div>&#160;<img src="https://images.newsfilecorp.com/files/7879/279158_01f5848d8463daa6_logo.jpg" id="corporateNewsLogo" alt="Corporate Logo" />To view the source version of this press release, please visit <a href="https://api.newsfilecorp.com/redirect/N3VRMhn7J0">https://www.newsfilecorp.com/release/279158</a><img src="https://api.newsfilecorp.com/newsinfo/279158/197" alt="" />

FONAR stockholders to receive $19.00 per share of common stock, in an all-cash transactionMelville, New York--(Newsfile Corp. - December 29, 2025) - FONAR Corporation (NASDAQ:FONR) (&#34;FONAR&#34; or the &#34;Company&#34;), The

FONR

FONAR Signs Definitive Agreement for "Take Private" Sale to Acquisition Group Led by CEO

Newsfile

FONAR to be acquired for $19 per share in cash.
Transaction represents a premium of 31.5% to the previous close.
Acquisition group led by FONAR's CEO Timothy Damadian.
Closing expected in the third fiscal quarter of 2026.
After completion, FONAR will delist from Nasdaq.

AI Market Analyst for Busy Investors

StockNews.AI helps you analyze the market 24/7 to spot opportunities and avoid losses — so you don't have to.

Trusted by Professionals From

Get Signals, Not Noise

Read Less, Know More

Less Research, More Insights

What We Provide

What Our Users Say

Powered By Premium Data Sources

Frequently Asked Questions